Next Article in Journal
Supramolecular Carotenoid Complexes of Enhanced Solubility and Stability—The Way of Bioavailability Improvement
Next Article in Special Issue
Sal B Alleviates Myocardial Ischemic Injury by Inhibiting TLR4 and the Priming Phase of NLRP3 Inflammasome
Previous Article in Journal
Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment
Previous Article in Special Issue
Hypoglycemic, Antiglycation, and Cytoprotective Properties of a Phenol-Rich Extract From Waste Peel of Punica granatum L. var. Dente di Cavallo DC2
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen

1
State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2
Key Laboratory of Modern Preparation of Traditional Chinese Medicine (TCM), Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(21), 3949; https://doi.org/10.3390/molecules24213949
Submission received: 4 October 2019 / Revised: 25 October 2019 / Accepted: 28 October 2019 / Published: 31 October 2019
(This article belongs to the Special Issue Natural Product Pharmacology and Medicinal Chemistry)

Abstract

:
Gac fruit (Momordica cochinchinensis Spreng) is a popular tropical fruit in southeast Asia. What is amazing is that its seeds (Momordicae Semen) and arils are traditional herbs with anti-tumor activity, and have protected human health for more than 1000 years. In recent years, its anti-tumor activity has received extensive attention and research. This manuscript summarized the chemical composition of saponins, fatty acids, volatile constituents, proteins, peptides, and other components from Momordicae Semen (MSE). The effect and mechanism of MSE and its extract on breast cancer, gastric cancer, lung cancer, esophagus cancer, melanomas, and human cervical epithelial carcinoma were discussed. In addition, its antioxidant, anti-inflammatory, and other pharmacological effects were also analyzed. We hope that this review will provide new ideas for the treatment of cancer and other diseases, and become a reference for the further research into complementary and alternative medicine.

Graphical Abstract

1. Introduction

Momordicae Semen (MSE) is the dry and mature seed bred in gac fruit. Momordica cochinchinensis is native to Southeast Asia, Vietnam, and mainly distributed in tropical regions such as Thailand, Laos, Cambodia, China, India, etc, [1]. Its name varies a lot in different countries, such as Fak Kao (Thailand), Mak Kao (Laos), and Bhat Ke rala (India) [2]. Its local name in Vietnam is red gac [3,4]. MSE is called Mubiezi in China, which was first published in the Kai bao Materia Medica in Song Dynasty and is mainly produced in Guangxi, Sichuan and Hubei province. The morphological and molecular diversity of 42 species of MSE from Australia; central, northern, and southern Vietnam; and Thailand were studied. The largest and most heavy MSE is from central Vietnam, and the lightest and smallest comes from Thailand [5].
Gac fruit is a tropical fruit that is used as a health food and traditional medicine in East and Southeast Asia. In Vietnam, the red aril that surrounds the seeds of mature gac fruit is usually consumed in the traditional recipe Vietnamese “Xoi Gac” [4]. The fruit, especially aril, is rich in carotenoids, β-carotene, and lycopene [6], which can be used for the treatment of infantile rickets, xeroma, and night blindness, according to the traditional Vietnamese documents [7,8]. In Thailand, immature gac fruits and shoots are taken as vegetables. In Guangxi province, southwest of China, people also have the custom of eating Momordica cochinchinensis seedlings, which are rich in vitamin C, vitamin B2, lycopene, beta carotene, and total carotenoids [9,10,11,12,13]. The anatomy of gac fruit from Guangxi, China is shown in Figure 1.
In China, MSE is commonly used in combination and can be used for the treatment of various diseases such as paronychia, hemorrhoids, and neurodermatitis [14]. Modern studies have shown that MSE has abundant antineoplastic activity. We aimed to review the research progress of MSE and summarize the pharmacological action and mechanisms of MSE. Prospects and development trends for the application and study of MSE are also described.

2. Chemical Composition

A large number of studies have shown that MSE mainly contains saponins, fatty acids, volatile constituents, terpenoids, lignin, steroids, proteins, peptides, and other components.
Oleanolic triterpenoid saponins with disaccharide chains are the main saponins in MSE. They mainly include saponins I, saponins II, gypsogenin 3-O-β-d-galactopyranosy (1→2)-[α-l-rhamnopyranosyl (1→3)]-β-d-glucuronopyranoside, and quillaic acid 3-O-β-d-galactopyranosyl (1→2)-[α-l-rhamnopyranosyl (1→3)]-β-d-glucuronopyranoside. The disaccharide saponins Ia-Ie, Ha-He, and saponins I and II also could be isolated from the roots of Momordica cochinchinensis [15]. Saponins I and saponins II are the most representative ones [16]. The structures of the main compounds are shown in Figure 2.
The aril of gac contains a high concentration of oil that is composed of several types of fatty acids. Similarly, fatty acids are also rich in the seeds [17]. MSE contained primarily stearic acid (60.5%), smaller amounts of linoleic (20%), oleic (9%), and palmitic acids (5%–6%), and trace amounts of arachidic, etc. [8]. Fourteen kinds of fatty acids were identified from MSE, accounting for 89.32% of the total fatty acid content, of which the unsaturated fatty acid content was 41.91% [18]. Gac aril contained 22% fatty acids by weight, composed of 32% oleic, 29% palmitic, and 28% linoleic acids. The fatty acids concentration was 101.98 mg·g−1 edible portion in gac pulp [19]. The unsaturated fatty acids of MSE have various effects on the body, such as adjusting blood fat, cholesterol, blood pressure, and preventing cancer [18]. The structures of the main compounds are shown in Figure 3.
The volatile constituents of MSE mainly consist of alkanes, esters, alcohols, ketones, ethers, aldehydes, and organic acids [20]. The structures of the main compounds are shown in Figure 4.
Terpenoids are common chemical constituents in plants, and the terpenoids from MSE are shown in Figure 5.
Lignin is widely found in nature and has abundant pharmacological activities. The lignin from MSE are shown in Figure 6.
Steroids are also important components in MSE, and their structures are shown in Figure 7.
The main proteins and peptides isolated from Momordica cochinchinensis (MCo) seeds are MCoCI, MCCTI-1 [21], MCoCC-1, MCoCC-2 [22], MCoTI-I to MCoTI-III [23], MCo-3 to MCo-6 [24], Cochinin B [25], and cochinchinin [26]. A chymotrypsin inhibitor 7514-Da named MCoCI, which belongs to the potato I inhibitor family, was isolated from the extract of MSE. It is the first chymotrypsin-specific serine protease inhibitor isolated from Cucurbitaceae [27]. MCCTI-1 and MCoTI-I to MCoTI-III are trypsin inhibitors, but no trypsin inhibitory effect was observed for MCoCC-1 within the 0.04–0.5 µM range [22]. MCoTI-I and MCoTI-II are head-to-tail cyclized peptides, whereas MCoTI-III is an acyclic peptide. MCoTI-I and MCoTI-II are extremely stable and can penetrate cells due to its small molecular weight. Thus, they are favorable choices as a framework for drug design applications [28]. MCo-3 to MCo-6 are not potent trypsin inhibitors, but can slightly inhibit cancer cell line MDA-MB-231. Cochinchinin is a ribosomal-inactivating protein with high cytotoxicity isolated from MSE [26].
The structures of some peptides and the other major compounds are shown in Figure 8, and the main compounds in MSE are shown in Table 1.

3. Pharmacological Effects

Anti-tumor activity is the most representative activity within the pharmacological activities of MSE. The anti-tumor effect may be mainly related to its pharmacological action of anti-oxidation, anti-inflammatory, anti-virus, and immune adjuvant.

3.1. Anti-Tumor Effect

MSE has been used in China for the treatment of oncological diseases for many years [36]. It has been proven that MSE can inhibit different tumors, which are listed in Table 2.

3.1.1. Breast Cancer

Breast cancer is the most common malignancy in women. It was also the second leading cause of cancer death among women after lung cancer [46]. Radiation therapies [47], targeted therapies [48,49], and endocrinotherapies [50] can be used for treating breast cancer, while TEC (taxotere, epirubicin, and cyclophosphamide) and CEF (cyclophosphamide, epirubicin, and fluorouracil) are the most common therapy method, but patients treated with TEC had a higher rate of neutropenia and leucopenia [51,52].
Ethanol extract of MSE can relieve the suffering caused by breast cancer. After 48 h of treatment with the extract, MDA-MB-231 cells proliferation was inhibited, cells apoptosis was induced, and the cell cycles were blocked in the dosage range of 0.1 to 0.4 mg·mL−1. Treated with MSE extract for 48 h, apoptotic evidences such as nuclear fragmentation, fluorescence, and typical apoptotic morphology could be found. Furthermore, the effects on MDA-MB-231 cells were in a dose-dependent manner. The mechanism induced apoptosis, and G2/M phase cell cycle arrest in MDA-MB-231 cells takes place to decrease the expression of the phosphatidylinositol 3-kinase/ protein kinase B (PI3K/Akt) pathway [40].
The ethyl acetate extract of MSE has been shown to have anti-tumor activity and was proved both in vivo and in vitro. Nude mouse xenotransplant models that were induced by injecting MDA-MB-231 cells subcutaneously into the right axilla of the mice proved that the extract could inhibit the growth of tumors. An experimental group was intraperitoneally injected with the ethyl acetate extract in the dosage of 50 mg·kg−1 (the 10% lethal dose) and 25 mg·kg−1 (the 5% lethal dose) once a day for 14 days. The results showed that the tumors in the group treated with the extract (25 or 50 mg·kg−1) were smaller and lighter [30]. A cell test also confirmed the anti-tumor activity of MSE. After 48 h of treatment with the extract, it showed a significant anti-proliferative effect on MDA-MB-231 cells in the dosage range of 8 to 250 μg·mL−1. Furthermore, the 50% inhibitory concentration (IC50) was 35.04 µg·mL−1. Its anti-tumor effect is attributed to inducing cell death, G2-phase arrest, apoptosis, and was mainly related to octadecanoic acid (9, Table 1, Figure 3), [(2S)-2-[(2R)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2H-furan-2-yl]-2-hydroxyethyl] hexadecanoate (100, Table 1, Figure 8), (2E,4E)-nona-2,4-dienal (97, Table 1, Figure 8), and other components [30].
The water extract of MSE also has effects on breast cancer ZR-75-30 cell lines. It blocked the cells’ growth, inhibited the migration and invasion, and downregulated the activity of MMP-2 and MMP-9 in a concentration-dependent manner between 30 and 120 μg·mL−1. The IC50 of the extract at 24 h, 48 h, and 72 h were 93.24 μg·mL−1, 34.04 μg·mL−1, and 53.43 μg·mL−1, respectively. The potential mechanism is attributed to reducing the expression of MMP-2 and MMP-9 [39].
Xiaojin Capsule, a Chinese patent medicine that contains MSE, is clinically used for the treatment of breast cancer. The anti-tumor effect is also supported by the results of basic experimental research. It was demonstrated by the zebrafish model, which was induced by transplanting fluorescently labeled human breast cancer cells (Michigan Cancer Foundation-7, MCF-7) into the yolk sac of zebrafish. Different concentrations (26.47 μg·mL−1, 88.24 μg·mL−1, and 264.72 μg·mL−1) were dissolved in the water of fish farming, and the tumor inhibition rate was calculated after 48 h of treatment. The growth inhibition rates were 31.66%, 54.35%, and 53.77%, respectively. When the concentration was 264.72 μg·mL−1, the inhibitory rate of zebrafish neovascularization was 21.74%, and the apoptosis induction rate was 28.92%. These results indicated that Xiaojin Capsule has the ability to inhibit breast cancer effectively in high concentrations [53]. The effect and mechanism of MSE on breast cancer are summarized in Figure 9.

3.1.2. Melanomas

Cutaneous melanoma causes around 90% of deaths in skin cancer patients [54]. The incidence has risen steadily worldwide over the last decades [55]. The incidence is increasing annually, and is currently 19.5 for men and 20.9 for women per 100,000 populations (World Standard Population year 2000) [56].
The anti-tumor effect of MSE is closely related to its extraction solvents, and the active parts were the aqueous extraction and ethanol extraction after comparing the effects of six different extraction solvents on melanoma cell lines (MM418C1 and D24). It was found there was a large amount of trypsin inhibitors in aqueous extraction, which could reduce the viability of MM418C1 and D24 melanoma cells. The effects of aqueous extracts and ethanol extracts of MSE on the growth of four different tissue-derived tumor cells (melanoma B16-F1, lung cancer cell A549, breast cancer cell MDA-MB-231, and esophageal carcinoma cells TE-13) in vitro were compared, and the results showed that aqueous extract can only inhibit the growth of B16-F1 cells weakly, but for the growth of the other three tumor cells, an effect can hardly be observed. On the contrary, ethanol extract could significantly inhibit the growth of four kinds of tumor cells, and the inhibition of B16–F1 melanoma cells was the most obvious [57]. Although a rich amount of saponins and phenolic compounds was detected in the water-saturated butanol part, it has no effect on the anti-cancer potential [39].
The ethyl acetate extract of MSE exhibited the strongest anti-proliferative effects on B16–F1 cells among other MSE fractions (water or petroleum ether) at the concentration of 5–200 μg·mL−1. B16–F1 cell proliferation was inhibited in a dose- and time-dependent manner between 5 and 40 μg·mL−1. Treated with 20 μg·mL−1 extract, melanin concentration significantly increased after 24 h, 48 h, and 72 h. The extract inhibited the proliferation of melanoma cells through inducing cell differentiation, which is characterized by proliferation inhibition, dendrite-like outgrowth, increased melanogenesis production, and an enhanced activity of tyrosinase. Its anti-melanoma effect is mainly attributed to (E)-3-(4-hydroxyphenyl)prop-2-enal (CMSP; 101, Table 1, Figure 8). The mechanism is to regulate the MAPK signaling pathway to inhibit the growth of melanoma B16–F1 cells and induce their differentiation [45].
It is reported that CMSP is the key component in the ethyl acetate extract of MSE. CMSP can inhibit B16–F1 cells in vivo and in vitro and has no harm to any organs within the therapeutic dose. [58]. A mouse melanoma model was used to evaluate the effects of CMSP on B16–F1 cells’ growth. The experimental group was intraperitoneally injected with 2 mg·kg−1 of CMSP every two days for three weeks, and the tumor volume was measured. On the 25th day, the mice were sacrificed and the tumor and liver were removed. It was found that the level of tumor tyrosinase in mice treated with CMSP increased, while the levels of melanoma markers S-100B, MIA-A, and MMP-9 decreased. Furthermore, the volumes and weights of the tumors in the mice of the experimental group were markedly lower than those in control mice. With different concentrations of CMSP (10, 20, or 40 μM) for 24, 48, or 72 h, the B16–F1 cells’ proliferation was inhibited in a dose- and time-dependent manner, and dendrite-like cellular protrusions can be found. Meanwhile, the expression level of tyrosinase was higher after treatment, while the expression of the melanoma cell markers S-100B and MIA were lower compared with control cells. Colony formation, cell migration, and the metastasis of B16–F1 cells can be inhibited by administering 20 μM CMSP for 24 h [58]. It indicated that the mechanism by which CMSP affects the viability of melanoma B16–F1 cells is the induction of B16-F1 melanoma cells differentiation via the Ras homolog gene family, member A- mitogen-activated protein kinase- Mitogen-activated protein kinase- Mitogen-activated protein kinase (RhoA–MAPK)signaling pathway.
In addition, MCoCC-1 (85, Table 1) is another anti-tumor active peptide isolated from MSE. Cytotoxicity assays were conducted to examine the effect of the peptides against four human cell lines, including colorectal adenocarcinoma (HT29), lung carcinoma cells (A549), melanoma cell line (MM96L), and a noncancerous control neonatal foreskin fibroblast cell line (NFF). It exhibited nonhemolytic and cytotoxic effects against human melanoma cell line MM96L [22].
Ethyl acetate, ethanol, and water extracts of MSE can all inhibit melanoma, and the monomer that plays a role is relatively clear. There may be synergies between them. The ethyl acetate extract of MSE can inhibit melanoma in vivo and in vitro. Furthermore, the compounds related to the efficacy have been clarified, and it is expected to provide a new solution for the treatment of melanoma. The anti-melanoma effects of different solvents are shown in Figure 10.

3.1.3. Lung Cancer

Lung cancer is the most commonly diagnosed cancer worldwide. In 2012, 1.8 million new lung cancer cases were estimated to have occurred globally, accounting for almost 13% of all new cancer cases (excluding non-melanoma skin cancer) [59].
MSE water extract can block Hepatoma 22 (H22) in vivo and A549 lung cancer cells in vitro. The anti-tumor effect on H22 was studied by an H22 subcutaneously transplanted tumor mice model. The tumor inhibition rate was 52.63% by giving 0.1 g·100g −1 extract through intragastric administration for 3 weeks. The effect on A549 was studied by vitro. It was found that the water extract could block the proliferation of A459 cells and the IC50 was about 13.7 mg·mL−1. It also blocked the growth of A549, which was inhibited in a dose-dependent manner from 2.5 to 20 mg·mL−1. The growth inhibition rate could reach 76.76% by applying 20 mg·mL−1 water extract to the A549 for 24 h. The morphology of A549 became smaller and rounded from the original rhombus with 5–20 mg·mL−1 water extract for 24 h [37].
The ethanol extract of MS plays an important role in the inhibition of lung cancer cells. The IC50 on lung cancer cells A549 and H1299 were 0.38 and 0.21 mg·mL−1 at 72 h, respectively. The extract dramatically inhibited the proliferation of A549 and H1299 from 0.05 to 0.4 mg·mL−1. The extract significantly induced apoptosis, and blocked the migratory and invasive performance of A549 cells between 0.1 and 0.4 mg·mL−1 for 48 h. The expression of STAT-3, MMP-2, and the level of B-cell lymphoma-2(Bcl-2) were significantly decreased, while the levels of E-cadherin, p53, and Bcl-2 Associated X Protein(Bax) were increased by administering the extract (0.2 and 0.4 mg·mL−1) for 48 h. The extract blocked the proliferation of A549 cells by inducing apoptosis, at least partly through the activation of p53 and inactivation of PI-3K/Akt signaling. The extract induces A549 apoptosis through the mitochondrial pathway and inhibits metastasis by the STAT-3 and MMP-2 pathways [41].

3.1.4. Gastric Cancer

Gastric cancer is still the fourth most common malignancy and remains the third leading cause of cancer-related death, following lung cancer and liver cancer [59].
The ethanol extract of MSE could inhibit gastric cancer cells GC7901 and MKN-28 in vitro. The IC50 values on SGC7901 and MKN-28 were 0.38 and 0.20 mg·mL−1, respectively. The extract induced the apoptosis of SGC7901 and MKN-28 and blocked the cell cycle at the S phase from 0.1 to 0.4 mg·mL−1 after treating for 48 h. It significantly downregulated the protein levels of Bcl-2 and PARP, but upregulated the protein levels of fas-associating protein with a novel death domain(Fas/FADD), Bax, and p53. Meanwhile, it has the potential to increase the activity of caspase-3 and caspase-9, and slightly affected that of caspase-8 in SGC-7901. The mechanism is via the regulation of the PARP and p53 signal pathways [42].

3.1.5. Esophageal Cancer

Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related mortality [59]. It is often accompanied with a poor prognosis, and the five-year survival ranges from 4% to 40% [60].
CMSP isolated from the ethanol extract is a major chemical component that inhibits some esophageal cancer cells. It was found that it inhibited the proliferation of Kyse30, TE-13, Ecal09, and Kyse180 at the concentration of 20 μg·mL−1. The cell cycles of TE-13 and Kyse30 could be blocked at the G0/G1 phase, and typical branched cell processes could be found. After 24 h, 48 h, and 72 h of administration, the expression levels of carcino-embryonic antigen (CEA) and squamous cell carcinoma antigen (SCC) were obviously lower than those in the control group from 10 to 40 μg·mL−1. Its mechanism is related to the upregulation of p-P38 in the MAPK signaling pathway and the downregulation of phosphorylation extracellular signal-regulated kinase (p-ERK) and phosphorylation Serine/threonine protein kinase/c-Jun /N-terminal kinase (p-SPKA/JNK) 43]. It can also restrain the migration and invasion of Kyse30 cells. Simultaneously, CMSP could decrease the expression levels of C-myc and N-myc in Kyse30 cells dramatically. It works by activating the RhoA–MAPK pathway and inducing the differentiation of Kyse30 cells [61].

3.1.6. Human Cervical Epithelial Carcinoma

Cervical cancer is the second most common cancer in females worldwide. Most are squamous cell carcinomas. Adenocarcinoma of the uterine cervix accounts worldwide for 10%–20% of all cervical cancers [62].
Cochinin B is a ribosome-inactivating protein that originates from MSE. It is a single-chain protein with a molecular weight of 28 kDa [25]. It is considered to have potent and broad anti-tumor activity. Cochinin B is very effective against human cervical epithelial carcinoma (HeLa), human embryonic kidney (HEK293), and human small cell lung cancer (NCI-H187) cell lines with IC50 values of 16.9, 114 and 574 nM, respectively [25].

3.2. General Pharmacological Action

In addition to antineoplastic activity, the other pharmacological effects of MSE are listed in Table 3.

3.2.1. Anti-Inflammatory

The anti-inflammatory effect of MSE is mainly attributed to the fatty oil and saponin components, and the content of fatty oil affects its anti-inflammatory effect, which was confirmed by an ear swelling model in mice. It was found that when the oil content is 20%, the anti-inflammatory and analgesic effects of MSE were most obvious [71]. Saponins also account for the anti-inflammatory effect. Quillaic acid 3-O-β-d-galactopyranosyl(1→2)-[α-L-rhamnopyranosyl(1→3)]-β-D-glucuronopyranoside (4, Table 1) showed an anti-inflammatory activity in RAW 264.7 cells by reducing the production of nitric oxide (NO) at the concentration of 20 µM for 1 h. The mechanism is to block the expression of nitric oxide and IL-6 via the NF-κB pathway, which was induced by lipopolysaccharides [29]. In addition, saponins I (1, Table 1) have the potential to treat inflammatory diseases and modulate macrophage activation. It can decrease NO production and downregulate the mRNA level of inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 in lipopolysaccharide (LPS)-activated RAW 264.7 cells from 20 to 40 µM. It can also control the translocation of p65 and p50 (the subunit of the transcription factor NF-κB) to the nucleus. The phosphorylation levels of inflammatory signaling proteins (IκBα, Src, and Syk) are reduced [63].

3.2.2. Antioxidant Activity

Both gac fruit and its seeds have antioxidant activity. In the fruit, vitamin E is the main natural antioxidant component [12]. Naturally occurring chymotrypsin inhibitors can prevent H2O2 formation [72]. Similarly, the chymotrypsin inhibitor MCoCI is the main antioxidant active ingredient in MSE [73]. The primary rat hepatocyte system showed that MCoCI pretreating hepatocytes for 24 h can significantly reverse the cell damage induced by tert-butyl hydroperoxide (t-BHP), as well as associated glutathione depletion and lipid peroxidation at 100 µg·mL−1 [74]. MCoCI can protect cells from acute oxidative stress induced by exogenous drugs to some extent, and its mechanism includes the prevention of reactive oxygen species formation [64]. In addition, the total antioxidant capacity (T-AOC), hydroxyl radical scavenging ability, and catalase activity of the extracts from the alkaloids part of MSE were determined by kit experiments, and the extract of MSE concentration was found to be positively correlated with T-AOC in the range of 26.880–94.080 μg·mL−1 [75]. Various reactive oxygen species in the body could cause oxidative damage to biological macromolecules such as nucleic acids (DNA, RNA), lipids, and proteins in the body, which leads to the occurrence of disease [76].

3.2.3. Immune Adjuvant

The ethanol extract of MSE is a relatively safe immune adjuvant. The ethanol extract of MSE could be used as a supplementary treatment for Newcastle disease (ND). Forty-eight chickens were immunized with the ND vaccine mixed with 0, 20, 40, or 80 μg of the extract for 35 days. It was found that the humoral immune response was enhanced and the vaccine mixed with 80 μg extract had the best effect. [77]. MSE has been shown to be effective in enhancing the immune response of chickens to avian influenza (H5N1) vaccination [78]. The FMDV (Foot-and-mouth disease virus) vaccine is a commercial oil-adjuvanted bivalent vaccine (serotypes O and Asia I). However, the probability of an effective immune response caused by vaccination for FMDV is small [79,80,81]. The immune adjuvant effect of MSE on the FMDV vaccine was also confirmed. It was found that the humoral immune response was increase by the oral administration or subcutaneous injection of the extract after inoculation with the FMDV vaccine. The extract tended to enhance serum immunoglobulin G (IgG) and IgG isotypes of mice immunosuppressed by a subcutaneous injection of dexamethasone [65]. Meanwhile, it has an adjuvant effect on the immune response induced by ovalbumin and has a low hemolytic activity [82]. Ovalbumin and MSE extract act in mice to induce higher specific antibody production, and ovalbumin-specific IgG titers are significantly increased among 50 to 100 μg [82]. In addition, MCoCI has immunopotentiating and anti-inflammatory effects [83]. MCoCI also can stimulate the proliferation of spleen cells, spleen lymphocytes, and bone marrow cells in the immune system, and promote the mitosis of spleen cells, which is usually accompanied by the induction of cytokines, such as IL-2 [84]. Quillaja saponaria Molina (Quil A) and aluminum salts used to be effective immune adjuvants, but their use was limited [85]. Quil A has hemolysis activity, and aluminum salts were found to be associated with muscle disease in humans [86]. By contrast, MSE is more safe and effective.

3.2.4. Antibacterial

The antibacterial and acaricidal effects are due to the saponins. It was found that the water extract of MSE can block the growth of Candida albicans, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa [66].

3.2.5. Protect Kidney Cell

It was discovered that the protective effect of the MSE on cisplatin-induced renal cell injury was mainly attributed to gypsogenin 3-O-β-d-galactopyranosy (1→2)-[α-l-rhamnopyranosyl (1→3)]-β-d-glucuronopyranoside (3, Table 1) and quillaic acid 3-O-β-d-galactopyranosyl (1→2)-[α-L- -rhamnopyranosyl (1→3)]-β-d-glucuronopyranoside (4, Table 1, Figure 2). They can decrease the toxicity of LLC-PK1 pig kidney epithelial cells induced by cisplatin at both 5 and 25 μM. Its mechanism is related to blocking the MAPK signaling cascade [67].

3.2.6. Promote the Healing of Gastric Ulcer

The ethanol extract of MSE can accelerate the ulcer healing of a rat model that is induced by ethanol and water immersion restraint stress (WRS). The extract was administrated intragastrically in a volume of 5 mL·kg−1 1 h before the WRS. It decreased gastric damage at the dosage of 50 to 100 mg·kg−1. The extract resists acute gastric mucosal damage by suppressing the production of pro-inflammatory cytokines, downregulating cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LOX), and increasing mucus synthesis [87]. Similarly, it can also accelerate the ulcer healing of another model of gastric ulcer induced by acetic acid. Administered orally at a dose of 200 mg·kg−1 extract once per day for 14 days after the acetic acid injection, the expression of mRNA (at day 7) as well as vascular endothelial growth factor (VEGF) protein (at day 14) were significantly ascended. Its mechanism is related to the upregulation of VEGF and angiogenesis in a rat model [67].

3.3. Induce Neurite Outgrowth

MSE have a nutritional effect on the nerves. Neurite length could reach to 40.20 ± 2.72 µm (seed extract treatment of 138 µg·mL−1) and 3.58 ± 0.42 µm (controls). The seed extract presented the same behavior with nerve growth factor (NGF) as the neurotrophic effects [17]. The 17-kDa protein obtained from MSE has the potential to induce neurite outgrowth, which was proved by a PC-12 cell model [69]. Nerve growth factor (NGF) has the ability to induce neuronal differentiation and repair the central nervous system. However, its use is limited because it fails to pass through the blood–brain barrier.

3.4. Prevented the Damages of Reproductive

MSE aril extract can prevent adverse male reproductive parameters and testicular damage induced with valproic acid (VPA). Male Wistar rats were pretreated with aqueous extract for 23 days before being co-administered with VPA induction for 10 days. It was found that MSE extract in various dosages (50, 100, and 200 mg·kg−1) could significantly improve the relative weights of epididymis plus vas deferens in VPA rats. The extract can not only prevent the damages of testicular tissue and seminiferous tubule diameters, it can also be safe for use. Its high antioxidant activities may be attributed to the mechanism of preventing testicular damage [70].

4. Toxicity

Although it is a seed of tropical fruit and has a medicinal history of nearly 1000 years in China, it is not a completely non-toxic herb as desired. The famous Compendium of Materia Medica in the Ming Dynasty recorded its toxicity. However, the exposure of toxicity in clinical application is rare. The reasons are as follows: firstly, the main way of administration is transdermal administration. Secondly, when taking medicine orally, it is necessary to remove fatty oils, and the daily dose is between 0.6 and 1.2 g [88].
Modern studies have shown that the toxic components in MSE are mainly saponin and cochinchinin. Both the water extract and the ethanol extract of MSE have certain toxicity [89,90,91,92]. Studies have shown that the median lethal dose (LD50) of intravenous injection of saponin in mice was 32.35 mg·kg−1, 37.34 mg·kg−1 in intraperitoneal injection, and 0.9582 g·kg−1 in oral. Furthermore, saponin has a hemolysis effect on rabbit red blood cells [89]. Another toxic component is cochinchinin. The mouse has an intraperitoneal injection of LD50 of 16 mg·kg−1, and the poisoned mouse died quietly [89]. The toxicity of the aqueous extract of MSE was assessed by the oral and intraperitoneal injection of 0.5 ml ·100 g−1 in mice for seven days. It was found that the LD50 of the extract was 4.03 g·kg−1 by oral administration and 146.17 mg·kg−1 by intraperitoneal injection [90]. The toxicity of high-concentration MSE water extract was evaluated by clinical trials. After approximately 8 to 12 g of MSE water extract is applied to 50 tumor patients, alanine aminotransferase is elevated, and may cause mild damage to the liver after long-term use. However, it is basically safe [92]. The toxicity of CMSP from MSE ethanol extract was observed by intraperitoneally injecting CMSP with 400 mg·kg−1 3 times per week for 28 days in mice. The change in the rate of micronucleus formation in mouse bone marrow cells was not obvious, and pathologic changes in visceral tissues can hardly be seen. CMSP has a relatively small toxic effect within the effective dosage range [91].
Many patients with lung cancer still suffer from facial and neck edema in the middle and late stages; five cases of pulmonary cancer edema were treated with MSE as the main drug. The results showed that the symptoms of edema disappeared, all kinds of symptoms were relieved, the condition was stable, and there were no obvious adverse reactions. Furthermore, the quality of life improved sharply [93].

5. Outlook

The anti-tumor activity of MSE is worthy of further investigation and development. In traditional medication experiences, it is often crushed into powders or pills are prepared after removing excessive fatty oils [94]. In fact, most of the chemical constituents may be involved in the anti-tumor effect. Modern research also shows that various extraction parts all play a role in blocking cancer cell growth, reproduction, migration, activation, or inhibition. Both traditional and modern evidences indicate that its anti-tumor effect may be a combination of multiple components.
The extraction solvent has a considerable influence on the pharmacological activity of MSE. Numerous studies have shown that different solvents MSE extracts have effects on different cancers, or different cancer cell lines that act on the same cancer. The combination of extracts from different solvents may work synergistically, such as breast cancer and melanoma. In addition, extracts from the same solvent can also block different cancers. For example, ethanol extract can inhibit both lung cancer and breast cancer. In order to achieve the desired therapeutic effect, in the clinical application, the extract of different solvents should be reasonably selected. Moreover, the purification and identification of compounds in different solvents is important for the clinical application and discovery of new treatment options.
It is of importance to fully explore the clinical use value of MSE. Although basic research studies have reinforced the anti-tumor activity of MSE, it is necessary to conduct clinical observation on the efficacy of MSE, and to systematically evaluate the anti-tumor adaptation range, optimal indication, and dose–effect relationship of MSE. Except for the inhibition of cancer, the improvement of clinical symptoms and the quality of life of patients should also be assessed due to the anti-inflammatory and analgesic activity of MSE.
At present, there are limited studies on the anti-tumor effects of MSE. Furthermore, relevant clinical trials have not yet started or been published until now. MSE deserves additional attention in the anti-tumor research field.

Author Contributions

X.-R.X., D.-K.Z., and L.H. conceived and designed the paper; C.-H.L., R.-C.X., and X.-C.W. gave some advice for improving the paper; B.C., F.W. and T.Z. gave some advice for improving the picture; X.-R.X. wrote the paper.

Funding

This project was financially supported by the National Natural Science Foundation of China (NO. 81873232) and Innovative research team of traditional Chinese medicine of Chengdu university of traditional Chinese medicine (CXTD2018006).

Conflicts of Interest

The authors declare that there is no conflict of interest regarding this publication.

References

  1. Nantachit, K.; Tuchinda, P.K.; Tuchinda, P. Antimicrobial activity of hexane and dichloromethane extracts from Momordica cochinchinensis (Lour.) Spreng leaves. Thai Pharm. Health Sci. J. 2009, 4, 15–20. [Google Scholar]
  2. Kubola, J.; Siriamornpun, S. Phytochemicals and antioxidant activity of different fruit fractions (peel, pulp, aril and seed) of Thai gac (Momordica cochinchinensis Spreng). Food Chem. 2011, 127, 1138–1145. [Google Scholar] [CrossRef] [PubMed]
  3. Iwamoto, M.; Okabe, H.; Yamauchi, T.; Tanaka, M.; Rokutani, Y.; Hara, S.; Mihashi, K.; Higuchi, R. Studies on the Constituents of Momordica cochinchinensis Spreng. I. Isolation and Characterization of the Seed Saponins, Momordica Sapponins I and II. Chem. Pharm. Bull. 1985, 33, 464–478. [Google Scholar] [CrossRef]
  4. Tran, X.T.; Parks, S.E.; Roach, P.D.; Golding, J.B.; Nguyen, M.H. Effects of maturity on physicochemical properties of G ac fruit (Momordica cochinchinensis Spreng.). Food Sci. Nutr. 2016, 4, 305–314. [Google Scholar] [CrossRef] [PubMed]
  5. Wimalasiri, D.; Piva, T.; Urban, S.; Huynh, T. Morphological and genetic diversity of Momordica cochinchinenesis (Cucurbitaceae) in Vietnam and Thailand. Genet. Resour. Crop Evol. 2015, 63, 19–33. [Google Scholar] [CrossRef]
  6. Ambrosini, G.L.; Alfonso, H.; Reid, A.; Mackerras, D.; Bremner, A.P.; Beilby, J.; Olsen, N.J.; Musk, A.W.; De Klerk, N.H. Plasma retinol and total carotenes and fracture risk after long-term supplementation with high doses of retinol. Nutrition 2014, 30, 551–556. [Google Scholar] [CrossRef]
  7. Vuong, L.T. Underutilized β-carotene–rich crops of Vietnam. Food Nutr. Bull. 2000, 21, 173–181. [Google Scholar] [CrossRef]
  8. Ishida, B.K.; Turner, C.; Chapman, M.H.; McKeon, T.A. Fatty acid and carotenoid composition of gac (Momordica cochinchinensis Spreng) fruit. J. Agric. Food Chem. 2004, 52, 274–279. [Google Scholar] [CrossRef]
  9. Do, T. Nhung cay Thuoc va vi Thuoc Vietnam Medicinal Plants and Drugs of VIETNAM; Nha Xuat Ban Khoa Hoc va Ky Thuat: Hanoi, Vietnam, 1999. [Google Scholar]
  10. West, C.E.; Poortvliet, E.J. The Carotenoid Content of Foods with Special Reference to Developing Countries; International Science and Technology Institute: Arlington, VA, USA, 1993. [Google Scholar]
  11. Aoki, H.; Kieu, N.T.M.; Kuze, N.; Tomisaka, K.; CHUYEN, N.V. Carotenoid pigments in GAC fruit (Momordica cochinchinensis SPRENG). Biosci. Biotechnol. Biochem. 2002, 66, 2479–2482. [Google Scholar] [CrossRef]
  12. Kha, T.C.; Nguyen, M.H.; Roach, P.D.; Parks, S.E.; Stathopoulos, C. Gac Fruit: Nutrient and Phytochemical Composition, and Options for Processing. Food Rev. Int. 2013, 29, 92–106. [Google Scholar] [CrossRef]
  13. Huang, S.W.; Xu, N.B.; Hu, L.; Huang, Z.L.; Zhao, J.; Li, R. Contents of Vitamin C and Vitamin B2 in Five Characteristic Vegetables of Baise. J. Youjiang Med. Coll. Natl. 2005, 5, 605–607. [Google Scholar]
  14. Wang, S.B. Four cases of external use of Mubiezi. Physician Online 2017, 11, 32–33. [Google Scholar]
  15. Kawamura, N.; Watanabe, H.; Oshio, H. Saponins from roots of Momordica cochinchinensis. Phytochemistry 1988, 27, 3585–3591. [Google Scholar] [CrossRef]
  16. Kubota, K.; Sato, M.; Murakami, T.; Yamagishi, T. Pharmacological studies on the saponin isolated from the seed of Momordica cochinchinensis Sprenger. J. Pharm. Soc. Jpn. 1971, 91, 174–179. [Google Scholar] [CrossRef]
  17. Do, T.V.T.; Fan, L.; Suhartini, W.; Girmatsion, M. Gac (Momordica cochinchinensis Spreng) fruit: A functional food and medicinal resource. J. Funct. Foods 2019, 62, 103512. [Google Scholar] [CrossRef]
  18. Ding, X.G.; Zhang, J.L.; Zheng, J.; Zhu, Y.Q.; Hou, D.Y. Gas Chromatography-Mass Spectrometry Analysis of Fatty Acids in Mubiezi. Lishizhen Med. Mater. Med. Res. 2005, 16, 202–203. [Google Scholar]
  19. Vuong, L.T.; Dueker, S.R.; Murphy, S.P. Plasma β-carotene and retinol concentrations of children increase after a 30-d supplementation with the fruit Momordica cochinchinensis (gac). Am. J. Clin. Nutr. 2002, 75, 872–879. [Google Scholar] [CrossRef]
  20. Xing, Y.H.; Zhou, R.; Gao, Z.Y. Chemical constituents of volatile oil from Mubiezi. GC-MS Analysis. J. Tradit. Chin. Med. Pharm. Bull. 2016, 15, 56–58. [Google Scholar]
  21. Huang, B.; Ng, T.; Fong, W.; Wan, C.; Yeung, H. Isolation of a trypsin inhibitor with deletion of N-terminal pentapeptide from the seeds of Momordica cochinchinensis, the Chinese drug mubiezhi. Int. J. Biochem. Cell Biol. 1999, 31, 707–715. [Google Scholar] [CrossRef]
  22. Chan, L.Y.; Wang, C.K.; Major, J.M.; Greenwood, K.P.; Lewis, R.J.; Craik, D.J.; Daly, N.L. Isolation and characterization of peptides from Momordica cochinchinensis seeds. J. Nat. Prod. 2009, 72, 1453–1458. [Google Scholar] [CrossRef]
  23. Hernandez, J.F.; Gagnon, J.; Chiche, L.; Nguyen, T.M.; Andrieu, J.P.; Heitz, A.; Trinh Hong, T.; Pham, T.T.C.; Le Nguyen, D. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 2000, 39, 5722–5730. [Google Scholar] [CrossRef] [PubMed]
  24. Chan, L.Y.; He, W.; Tan, N.; Zeng, G.; Craik, D.J.; Daly, N.L. A new family of cystine knot peptides from the seeds of Momordica cochinchinensis. Peptides 2013, 39, 29–35. [Google Scholar] [CrossRef] [PubMed]
  25. Chuethong, J.; Oda, K.; Sakurai, H.; Saiki, I.; Leelamanit, W. Cochinin B, a novel ribosome-inactivating protein from the seeds of Momordica cochinchinensis. Biol. Pharm. Bull. 2007, 30, 428–432. [Google Scholar] [CrossRef] [PubMed]
  26. Zheng, S.; Li, G.E. Purification and Properties of Momordica cochinchinensis. Biochim. Biophys. Acta 1992, 24, 311–316. [Google Scholar]
  27. Tsoi, A.Y.; Wong, R.C.; Ng, T.B.; Fong, W.P. First report on a potato I family chymotrypsin inhibitor from the seeds of a Cucurbitaceous plant, Momordica cochinchinensis. Biol. Chem. 2004, 385, 185–189. [Google Scholar] [CrossRef]
  28. Du, J.; Chan, L.Y.; Poth, A.G.; Craik, D.J. Discovery and Characterization of Cyclic and Acyclic Trypsin Inhibitors from Momordica dioica. J. Nat. Prod. 2019, 82, 293–300. [Google Scholar] [CrossRef]
  29. Jung, K.; Chin, Y.W.; Yoon, K.d.; Chae, H.S.; Kim, C.Y.; Yoo, H.; Kim, J. Anti-inflammatory properties of a triterpenoidal glycoside from Momordica cochinchinensis in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol. 2013, 35, 8–14. [Google Scholar] [CrossRef]
  30. Zheng, L.; Zhang, Y.; Liu, Y.; Yang, X.O.; Zhan, Y. Momordica cochinchinensis Spreng. seed extract suppresses breast cancer growth by inducing cell cycle arrest and apoptosis. Mol. Med. Rep. 2015, 12, 6300–6310. [Google Scholar] [CrossRef]
  31. Kan, L.D.; Hu, Q.; Cao, Z.M.; Song, X.; Cao, X.L. Study on the chemical constituents of unsaponifiable substances in the Mubiezi fatty oil. China J. Chin. Mater. Med. 2006, 31, 1441–1444. [Google Scholar]
  32. Wang, M.Y.; Zhan, Z.B.; Xiong, Y.; Li, X.B. Studies on liposoluble constituents from Momordicae Semen. Zhongguo Zhong Yao Za Zhi 2018, 43, 1175–1181. [Google Scholar]
  33. Shan, M.D.; Hu, L.H.; Chen, Z.L. A new multiflorane triterpenoid ester from Momordica cochinchinensis Spreng. Nat. Prod. Lett. 2001, 15, 139–145. [Google Scholar] [CrossRef] [PubMed]
  34. Liu, T.; Shi, J.F.; Wu, X.Z. Research on chemical constituents of Mongolian medicine mubiezi. Acta Acad. Med. Neimongol. 2010, 32, 390–393. [Google Scholar]
  35. Wang, M.; Zhan, Z.; Xiong, Y.; Zhang, Y.; Li, X. Cytotoxic and anti-inflammatory constituents from Momordica cochinchinensis seeds. Fitoterapia 2019, 139, 104360. [Google Scholar] [CrossRef] [PubMed]
  36. Zhang, H.Y.; Sun, M.M. Mubiezi oil treatment of paronychia. China’s Naturop. 2017, 25, 53. [Google Scholar]
  37. Zhang, Q.Z.; Duan, Y.J.; Du, G.J. Research on anti-tumor effect of Mubiezi decoction. J. Henan Univ. Med. Ed. 2017, 36, 229–234. [Google Scholar]
  38. Zheng, L.; Zhang, Y.M.; Zhan, Y.Z.; Liu, C.X. Momordica cochinchinensis Seed Extracts Suppress Migration and Invasion of Human Breast Cancer ZR-75-30 Cells Via Down-regulating MMP-2 and MMP-9. Asian Pac. J. Cancer Prev. 2014, 15, 1105–1110. [Google Scholar] [CrossRef]
  39. Le, A.; Huynh, T.; Parks, S.; Nguyen, M.; Roach, P. Bioactive composition, antioxidant activity, and anticancer potential of freeze-dried extracts from defatted Gac (Momordica cochinchinensis Spreng) seeds. Medicines 2018, 5, 104. [Google Scholar] [CrossRef]
  40. Meng, L.Y.; Liu, H.R.; Shen, Y.; Yu, Y.Q.; Tao, X. Cochinchina momordica seed extract induces G2/M arrest and apoptosis in human breast cancer MDA-MB-231 cells by modulating the PI3K/Akt pathway. Asian Pac. J. Cancer Prev. 2011, 12, 3483–3488. [Google Scholar]
  41. Shen, Y.; Meng, L.; Sun, H.; Zhu, Y.; Liu, H. Cochinchina momordica seed suppresses proliferation and metastasis in human lung cancer cells by regulating multiple molecular targets. Am. J. Chin. Med. 2015, 43, 149–166. [Google Scholar] [CrossRef]
  42. Liu, H.R.; Meng, L.Y.; Lin, Z.Y.; Shen, Y.; Yu, Y.Q.; Zhu, Y.Z. Cochinchina momordica seed extract induces apoptosis and cell cycle arrest in human gastric cancer cells via PARP and p53 signal pathways. Nutr. Cancer 2012, 64, 1070–1077. [Google Scholar] [CrossRef]
  43. Shan, Y.N.; Dong, P.; Wu, Y.P.; Wei, S.-S.; Cui, W.X.; Ma, M.; Zhao, L.M.; Shan, B.E. Differentiation of esophageal cancer TE-13 cells induced by P-hydroxycinnamic aldehyde and its mechanism. Chin. J. Cancer Biother. 2017, 24, 30–37. [Google Scholar]
  44. Wong, K.L.; Wong, R.N.; Zhang, L.; Liu, W.K.; Ng, T.B.; Shaw, P.C.; Kwok, P.C.; Lai, Y.M.; Zhang, Z.J.; Zhang, Y.; et al. Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential. Chin. Med. 2014, 9, 19. [Google Scholar] [CrossRef] [PubMed]
  45. Zhao, L.M.; Han, L.N.; Ren, F.Z.; Chen, S.H.; Liu, L.-H.; Wang, M.X.; Sang, M.X.; Shan, B.E. An ester extract of Cochinchina momordica seeds induces differentiation of melanoma B16 F1 cells via MAPKs signaling. Asian Pac. J. Cancer Prev. 2012, 13, 3795–3802. [Google Scholar] [CrossRef] [PubMed]
  46. DeSantis, C.; Ma, J.; Bryan, L.; Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 2014, 64, 52–62. [Google Scholar] [CrossRef] [PubMed]
  47. Chung, M.J.; Lee, G.J.; Suh, Y.J.; Lee, H.C.; Lee, S.W.; Jeong, S.; Lee, J.W.; Kim, S.H.; Kang, D.G.; Lee, J.H. Setup Error and Effectiveness of Weekly Image-Guided Radiation Therapy of TomoDirect for Early Breast Cancer. Cancer Res. Treat. 2015, 47, 774–780. [Google Scholar] [CrossRef]
  48. Swain, S.M.; Baselga, J.; Kim, S.B.; Ro, J.; Semiglazov, V.; Campone, M.; Ciruelos, E.; Ferrero, J.M.; Schneeweiss, A.; Heeson, S.; et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N. Engl. J. Med. 2015, 372, 724–734. [Google Scholar] [CrossRef]
  49. Barton, M.K. Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple-negative breast cancer. CA Cancer J. Clin. 2014, 64, 155–156. [Google Scholar] [CrossRef]
  50. Figg, W.D., II; Cook, K.; Clarke, R. Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer. Cancer Biol. Ther. 2014, 15, 1586–1587. [Google Scholar] [CrossRef] [Green Version]
  51. Chen, X.; Ye, G.; Zhang, C.; Li, X.; Chen, Y.; Xie, X.; Zheng, H.; Cao, Y.; Wu, K.; Ni, D.; et al. Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: Results from the NATT trial in triple negative or HER2 positive breast cancer. Breast Cancer Res. Treat. 2013, 142, 549–558. [Google Scholar] [CrossRef]
  52. Ando, M.; Yamauchi, H.; Aogi, K.; Shimizu, S.; Iwata, H.; Masuda, N.; Yamamoto, N.; Inoue, K.; Ohono, S.; Kuroi, K.; et al. Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression. Breast Cancer Res. Treat. 2014, 145, 401–409. [Google Scholar] [CrossRef]
  53. Huang, Z.J.; Lan, X.H.; Zhao, G.; Xu, Y.Q.; Wu, M.Q.; Zhang, Y.; Li, C.Q. Antitumor effect of Xiaojin Capsules on xenotransplanted tumor in zebrafish. Chin. Tradit. Pat. Med. 2014, 37, 1029–1033. [Google Scholar]
  54. Garbe, C.; Peris, K.; Hauschild, A.; Saiag, P.; Middleton, M.; Spatz, A.; Grob, J.J.; Malvehy, J.; Newton-Bishop, J.; Stratigos, A.; et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur. J. Cancer 2010, 46, 270–283. [Google Scholar] [CrossRef] [PubMed]
  55. Hubner, J.; Waldmann, A.; Geller, A.C.; Weinstock, M.A.; Eisemann, N.; Noftz, M.; Bertram, S.; Nolte, S.; Volkmer, B.; Greinert, R.; et al. Interval cancers after skin cancer screening: Incidence, tumour characteristics and risk factors for cutaneous melanoma. Br. J. Cancer 2017, 116, 253–259. [Google Scholar] [CrossRef] [PubMed]
  56. Claeson, M.; Holmstrom, P.; Hallberg, S.; Gillstedt, M.; Gonzalez, H.; Wennberg, A.M.; Paoli, J. Multiple Primary Melanomas: A Common Occurrence in Western Sweden. Acta Derm.-Venereol. 2017, 97, 715–719. [Google Scholar] [CrossRef] [Green Version]
  57. Zhao, L.M.; Han, L.N.; Shan, B.E.; Pan, X.M.; Liu, L.H.; Li, X.G. Preliminary study on anti-tumor activity of Mubiezi extract. Carcinog. Distortion Mutat. 2010, 22, 19–23. [Google Scholar]
  58. Zhao, L.M.; Sun, G.G.; Han, L.N.; Liu, L.H.; Ren, F.Z.; Li, L.; Ma, M.; Shan, B.E. P-hydroxycinnamaldehyde induces B16-F1 melanoma cell differentiation via the RhoA-MAPK signaling pathway. Cell. Physiol. Biochem. 2016, 38, 2247–2260. [Google Scholar] [CrossRef]
  59. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359–E386. [Google Scholar] [CrossRef]
  60. Malhotra, G.K.; Yanala, U.; Ravipati, A.; Follet, M.; Vijayakumar, M.; Are, C. Global trends in esophageal cancer. J. Surg. Oncol. 2017, 115, 564–579. [Google Scholar] [CrossRef] [Green Version]
  61. Dai, S.L.; Wu, H.; Zhao, R.Y.; Ma, M.; Zhang, C.; Zhao, L.M.; Shan, B.E. Study on the differentiation of Kyse30 cells induced by P-hydroxycinnamic aldehyde and its mechanism of action. Chin. Tradit. Herb. Drugs 2018, 49, 610–618. [Google Scholar]
  62. Adegoke, O.; Kulasingam, S.; Virnig, B. Cervical cancer trends in the United States: A 35-year population-based analysis. J. Womens Health 2012, 21, 1031–1037. [Google Scholar] [CrossRef]
  63. Yu, J.S.; Kim, J.H.; Lee, S.; Jung, K.; Kim, K.H.; Cho, J.Y. Src/Syk-targeted anti-inflammatory actions of triterpenoidal saponins from Gac (Momordica cochinchinensis) seeds. Am. J. Chin. Med. 2017, 45, 459–473. [Google Scholar] [CrossRef] [PubMed]
  64. Frenkel, K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther. 1992, 53, 127–166. [Google Scholar] [CrossRef]
  65. Sakwiwatkul, K.; Li, R.L.; Song, X.M.; Hu, S.H. Effect of the extract made from Cochinchina momordica seeds on the humoral immune responses of mice to a commercial foot and mouth disease vaccine (serotypes O and Asia 1). Microbiol. Immunol. 2010, 54, 31–37. [Google Scholar] [CrossRef] [PubMed]
  66. Jiang, R.H.M. Separation, Purification, Identification and Activity of Saponins of Mubiezi; Shandong University: Shandong, China, 2009. [Google Scholar]
  67. Jung, K.; Lee, D.; Yu, J.S.; Namgung, H.; Kang, K.S.; Kim, K.H. Protective effect and mechanism of action of saponins isolated from the seeds of gac (Momordica cochinchinensis Spreng.) against cisplatin-induced damage in LLC-PK1 kidney cells. Bioorgan. Med. Chem. Lett. 2016, 26, 1466–1470. [Google Scholar] [CrossRef] [PubMed]
  68. Kang, J.M.; Kim, N.; Kim, B.; Kim, J.-H.; Lee, B.-Y.; Park, J.H.; Lee, M.K.; Lee, H.S.; Kim, J.S.; Jung, H.C. Enhancement of gastric ulcer healing and angiogenesis by cochinchina Momordica seed extract in rats. J. Korean Med. Sci. 2010, 25, 875–881. [Google Scholar] [CrossRef] [PubMed]
  69. Mazzio, E.; Badisa, R.; Eyunni, S.; Ablordeppey, S.; George, B.; Soliman, K. Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis). Evid.-Based Complement. Altern. Med. 2018, 2018, 8953958. [Google Scholar] [CrossRef]
  70. Sukhorum, W.; Sampannang, A.; Sripanidkulchai, B.; Iamsaard, S. Momordica cochinchinensis (L.) Spreng. aril extract prevents adverse reproductive parameters of male rats induced with valproic acid. Int. J. Morphol. 2016, 34, 870–876. [Google Scholar] [CrossRef]
  71. Jun, S.F.; Lu, J.X.; Lu, C.; Hui, C.H. Comparison of Anti-inflammatory and Analgesic Effects of Different Oil Content Mubiezi Cream. Lishizhen Med. Mater. Med. Res. 2010, 21, 1084–1085. [Google Scholar]
  72. Frenkel, K.; Chrzan, K.; Ryan, C.A.; Wiesner, R.; Troll, W. Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes. Carcinogenesis 1987, 8, 1207–1212. [Google Scholar] [CrossRef]
  73. Kennedy, A.R. Chemopreventive agents: Protease inhibitors. Pharmacol. Ther. 1998, 78, 167–209. [Google Scholar] [CrossRef]
  74. Tsoi, A.Y.K.; Ng, T.B.; Fong, W.P. Antioxidative effect of a chymotrypsin inhibitor from Momordica cochinchinensis (Cucurbitaceae) seeds in a primary rat hepatocyte culture. J. Pept. Sci. 2005, 11, 665–668. [Google Scholar] [CrossRef] [PubMed]
  75. Xing, Y.H.; Xian, K.D.; Hou, S.P. Study on Antioxidant Activity of Extracts from Alkaloids of Momordica cochinchinensis. Shaanxi Agric. Sci. 2017, 63, 52–53. [Google Scholar]
  76. Ju, Z.Q. Study on Oxidative Damaged Diseases and Antioxidant Traditional Chinese Medicine. J. Anhui Univ. Chin. Med. 1997, 16, 60–61. [Google Scholar]
  77. Xiao, C.; Bao, G.; Hu, S. Enhancement of immune responses to Newcastle disease vaccine by a supplement of extract of Momordica cochinchinensis (Lour.) Spreng. seeds. Poult. Sci. 2009, 88, 2293–2297. [Google Scholar] [CrossRef] [PubMed]
  78. Rajput, Z.I.; Xiao, C.-W.; Hu, S.-H.; Arijo, A.G.; Soomro, N.M. Improvement of the efficacy of influenza vaccination (H5N1) in chicken by using extract of Cochinchina momordica seed (ECMS). J. Zhejiang Univ. Sci. B 2007, 8, 331–337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. He, Q.; Chen, H.; Wu, B.; Suo, X.; Fang, L.; Wang, C. The Detection of Serum Antibody Against Hog Cholera, Porcine Parvovirus and the Foot and Mouth Disease on 44 Pig farmas of Six Province. Chin. J. Prev. Vet. Med. 2000, 22, 5–9. [Google Scholar]
  80. Wang, Y. Analysis of serum antibodies elicited by foot and mouth disease vaccine in pigs. Fujian Anim. Husb. Vet. Med. 2007, 6, 32. [Google Scholar]
  81. Wei, D. Discussion on the failure of vaccination in animals. J. Anim. Sci. Vet. Med. 2007, 26, 33–34. [Google Scholar]
  82. Xiao, C.; Hu, S.; Rajput, Z.I. Adjuvant effect of an extract from Cochinchina momordica seeds on the immune responses to ovalbumin in mice. Front. Agric. China 2007, 1, 90–95. [Google Scholar] [CrossRef]
  83. Tsoi, A.Y.K.; NG, T.B.; Fong, W.P. Immunomodulatory activity of a chymotrypsin inhibitor from Momordica cochinchinensis seeds. J. Pept. Sci. 2006, 12, 605–611. [Google Scholar] [CrossRef]
  84. Shibata, H.; Yamamoto, I. Induction of prolonged elevation of interleukin 2 in the culture medium of murine splenocytes by their precultivation before mitogenic stimulations and its potentiation by glucocorticoid treatment and restraint stress loading. Jpn. J. Pharmacol. 1990, 52, 523–532. [Google Scholar] [CrossRef] [PubMed]
  85. Xiao, C.; Rajput, Z.I.; Hu, S. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine 2007, 25, 4795–4800. [Google Scholar] [CrossRef] [PubMed]
  86. Oda, K.; Matsuda, H.; Murakami, T.; Katayama, S.; Ohgitani, T.; Yoshikawa, M. Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol. Chem. 2000, 381, 67–74. [Google Scholar] [CrossRef] [PubMed]
  87. Kang, J.M.; Kim, N.; Kim, B.; Kim, J.-H.; Lee, B.-Y.; Park, J.H.; Lee, M.K.; Lee, H.S.; Jang, I.-J.; Kim, J.S. Gastroprotective action of cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA 2/5-LOX pathway. Dig. Dis. Sci. 2009, 54, 2549. [Google Scholar] [CrossRef] [PubMed]
  88. Tang, W.; Bu, B.; Gui, W. Rescue analysis of five cases of acute poisoning of Mubiezi. Chin. Gen. Pract. 2009, 12, 2061. [Google Scholar]
  89. Wang, Y.S.; Zhao, L.N.; Zhang, Z.L. Research progress on the history and toxicity of processing of Momordica cochinchinensis. In Papers Collection of 2010 Forum on Processing Technology, Academic Exchange and Industrial Development of Traditional Chinese Medicine[c]; Chengdu, China, 2010. [Google Scholar]
  90. Zheng, L.; Yang, R.F.; Yang, F.; Li, M.Y. Experimental study on acute toxicity of hibiscus extract in mice. China Pharm. 2017, 20, 2242–2243. [Google Scholar]
  91. MA, M.; Bai, H.; Li, X. Toxicity of ethanol extract of Mubiezi to hydroxycinnamic aldehyde in mice. Carcinog. Distortion Mutat. 2018, 30, 452–456. [Google Scholar]
  92. Wang, H.; Fu, Q.; Wang, X. Analysis of side effects of over-containing Mubiezi decoction. Beijing Chin. Med. 2011, 30, 942–944. [Google Scholar]
  93. Wang, L.; Zeng, Y. Clinical observation and experience of 5 cases of lung cancer edema treated with Mubiezi. Stud. Trace Elem. Health 2013, 30, 31. [Google Scholar]
  94. Xiong, X.; He, Y.-N.; Feng, B.; Pan, Y.; Zhang, H.-Z.; Ke, X.-M.; Zhang, Y.; Yang, M.L.; Han, L.; Zhang, D.-K. Screening for the anti-inflammation quality markers of Xiaojin Pills based on HPLC-MS/MS method, COX-2 inhibition test and protein interaction network. Sci. Rep. 2018, 8, 7454. [Google Scholar] [CrossRef]
Figure 1. The anatomy of gac fruit: (a) gac fruit, (b) longitudinal section of fruit (1. Pulp, 2. Aril, 3. Seed, 4. Peel with spines), (c) the seeds of gac frui.
Figure 1. The anatomy of gac fruit: (a) gac fruit, (b) longitudinal section of fruit (1. Pulp, 2. Aril, 3. Seed, 4. Peel with spines), (c) the seeds of gac frui.
Molecules 24 03949 g001
Figure 2. Saponins from Momordicae Semen.
Figure 2. Saponins from Momordicae Semen.
Molecules 24 03949 g002
Figure 3. Fatty acid from Momordicae Semen.
Figure 3. Fatty acid from Momordicae Semen.
Molecules 24 03949 g003
Figure 4. Volatile constituents from Momordicae Semen.
Figure 4. Volatile constituents from Momordicae Semen.
Molecules 24 03949 g004
Figure 5. Terpenoids constituents from Momordicae Semen.
Figure 5. Terpenoids constituents from Momordicae Semen.
Molecules 24 03949 g005
Figure 6. Lignin from Momordicae Semen.
Figure 6. Lignin from Momordicae Semen.
Molecules 24 03949 g006
Figure 7. Steroids from Momordicae Semen.
Figure 7. Steroids from Momordicae Semen.
Molecules 24 03949 g007
Figure 8. Some peptides and other constituents from Momordicae Semen.
Figure 8. Some peptides and other constituents from Momordicae Semen.
Molecules 24 03949 g008
Figure 9. Anti-breast cancer effects and mechanisms of Momordicae Semen.
Figure 9. Anti-breast cancer effects and mechanisms of Momordicae Semen.
Molecules 24 03949 g009
Figure 10. Anti-melanoma effects and mechanisms of Momordicae Semen.
Figure 10. Anti-melanoma effects and mechanisms of Momordicae Semen.
Molecules 24 03949 g010
Table 1. Main chemical components in Momordicae Semen.
Table 1. Main chemical components in Momordicae Semen.
No.Chemical ClassSpecific Chemical CompositionRefs
1SaponinsSaponins I[3]
2Saponins II[3]
3Gypsogenin 3-O-β-D-galactopyranosy (1→2)- [α-L-rhamnopyranosyl (1→3)]-β-D-glucuronopyranoside[29]
4Quillaic acid 3-O-β-D-galactopyranosyl (1→2)-[α-L- -rhamnopyranosyl (1→3)]-β-D-glucuronopyranoside[29]
5Fatty acidsPentadecanoic acid[18]
6Hexadec-11-enoic acid[18]
7Hexadecanoic acid[18]
8Heptadecanoic acid[18]
9Octadecanoic acid[18]
10(9Z,12Z)-octadeca-9,12-dienoic acid[18]
11(Z)-octadec-13-enoic acid[18]
12Octadeca-10,13-dienoic acid[18]
13Nonadecanoic acid[18]
14Nonadec-10-enoic acid[18]
15Icosanoic acid[18]
16(Z)-icos-11-enoic acid[18]
17Docosanoic acid[30]
18Octadec-6-enoic acid[31]
4-hydroxybenzoic acid
19 Butan-1-ol[20]
20Volatile
constituents
Pentanal[20]
21Pentan-1-ol[20]
22Pentan-2-ol[20]
23Heptan-2-ol[20]
24Hexanal[20]
25Heptanal[20]
261-ethenoxybutane[20]
271,1-diethoxyethane[20]
282-ethoxybutane[20]
292-ethoxypropane[20]
304-methyl-1,3-dioxane[20]
312-hydroxypropanoic acid[20]
32Pentyl formate[20]
33 Ethyl pentanoate[20]
34Ethyl acetate[20]
353-methoxypropane-1,2-diol[20]
36Pentyl acetate[20]
37 1-acetyloxyethyl acetate[20]
382-ethylbutanoic acid[20]
391,3-dioxan-5-ol[20]
40Butane-1,3-diol[20]
415-methylnonan-5-ol[20]
422-methoxy-1,3-dioxolane[20]
432-methylpentan-1-ol[20]
441-(1-ethoxyethoxy)butane[20]
451-(1-ethoxyethoxy)pentane[20]
463-hydroxybutanal[20]
472-oxopropanal[20]
481,3-dioxolane[20]
495-ethylheptan-2-ol[20]
502,3-dimethyloxirane[20]
511,1-diethoxypentane[20]
522,4-dimethyloctan-4-ol[20]
531-methoxypropan-2-yl acetate[20]
541-(1-methylethoxy)-2-propanol[20]
552,6-dimethylheptane-3,5-dione[20]
564-methoxy-4-oxobutanoic acid[20]
571,1,2-trimethyl-3-methylenecyclopropane[20]
583,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one[20]
Trimethylsilyl
59Terpenoid(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-ol[31]
60(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,7,8,9,10,12,12a,13,14-dodecahydropicen-3-ol[31]
61(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol[32]
623,29-di-o-(p-methoxy)benzoylmultiflora-8-ene- 3 a,29-diol-7-one[33]
63(10R)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid[34]
64(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid[34]
65(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-3-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,3,4a,5,7,8,9,10,12,12a,13,14-dodecahydro-1H-picen-6-one[31]
66(3R,6aS,6bS,8aS,11R,12aR,14bR)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,7,8,9,10,12,12a,13-decahydropicen-3-ol[31]
67Lignin4-[(2S,3R)-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]phenol[32]
687-methoxy-2,3-dihydro-1-benzofuran-5-yl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]phenol[32]
693-hydroxy-1-[(2S,3R)-3-(hydroxymethyl)-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propan-1-one[32]
70(7R, 8S, 8′R)-4, 4′, 9-trihydroxy-7, 9′-epoxy-8, 8′-lignan[32]
71(1S,2R)-1-(4-hydroxy-3-methoxyphenyl)-2-[4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]propane-1,3-diol[32]
72(7 R, 8 S, 7′ R, 8′ S, 7″ S, 8″ R)-4′-guaiacylglyceryl-3-demethoxypinoresinol[35]
733-demethoxyl- ethletianol C[35]
74(7′R,8′S)-7-oxo-9, 4′, 9′-trihydroxy-4, 7′-epoxy -3, 8′-neolignan[35]
75(7′S,8′S)-4-methoxyl-7-hydroxylmethyl-9′-hydroxy-4, 7′-epoxy-3, 8′-neolignan[35]
76(2R, 3S, 4S)-2,4-bis-(4-hydroxy-phenyl)-tetrahydrofuran-3-ol[35]
774-[(2S,3R,4S)-4-[(S)-hydroxy-(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol[31]
78 (3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol[32]
79 Steroid(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol[31]
80(3S,5S)-17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol[31]
(E)-3-(4-hydroxyphenyl)prop-2-enal
(1S,2R)-1-(4-hydroxy-3-methoxyphenyl)-2-[4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]propane-1,3-diol
81Acyclic peptidesMCo-3[24]
82MCo-4[24]
83MCo-5[24]
84MCo-6[24]
85MCoCC-1[22]
86MCoCC-2[22]
87MCoTI-III[23]
88MCoTI-V[28]
89 MCoTI-I[23]
90Cyclic peptides(3S,6S,9S,12S,15S)-3,9-bis[(2S)-butan-2-yl]-6,12,15-tris(2-methylpropyl)-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone[32]
91 Clavatustide c[32]
92 MCoTI-II[23]
92Trypsin inhibitorsMCoTI-II
89MCoTI-I
93MCoCI[27]
87MCoTI-III
94MCCTI-1[21]
95ProteinsCochinin B[25]
96Cochinchinin[26]
97 (2E,4E)-nona-2,4-dienal[30]
98 Heptacosane[34]
99 Pentatriacontan-18-one[34]
100Others[(2S)-2-[(2R)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2H-furan-2-yl]-2-hydroxyethyl] hexadecanoate[30]
101 (E)-3-(4-hydroxyphenyl)prop-2-enal[32]
102 4-hydroxybenzoic acid[32]
1035,5-dimethyl-cyclohex-3-en-1-ol[30]
Table 2. Anti-tumor effects of Momordicae Semen extracts.
Table 2. Anti-tumor effects of Momordicae Semen extracts.
SolventTumorCancer CellEffectObservationRefs
WaterLung cancerA549Inhibit proliferation and migrationIn vitro[37]
Breast cancerZR-75-30Inhibit proliferation and migrationIn vitro[38]
MelanomaMM418C1,D24Lowered vitalityIn vitro[39]
Human cervical epithelial carcinomaHuman cervical epithelial carcinomaIn vitro[25]
EthanolBreast cancerMDA-MB-231Inducing G2/M block and apoptosisIn vitro[40]
Lung cancerA549, H1299Inducing apoptosis, inhibiting invasion and migrationIn vitro[41]
Gastric cancerSGC7901, MKN-28Apoptosis-inducingIn vitro[42]
Esophagus cancerTE-13, Kyse30Rhoa-MAPK signaling pathway is regulatedIn vitro[43]
Human cervical epithelial carcinomaHuman cervical epithelial carcinomaIn vitro[44]
Ethyl acetateBreast cancerMDA-MB-231G2 cell cycle arrest, apoptosis and growth inhibitionIn vitro and in vivo[30]
MelanomaB16-F1Inhibit proliferation and induce differentiationIn vitro and in vivo[45]
Table 3. The general pharmacological effects and mechanisms of Momordicae Semen.
Table 3. The general pharmacological effects and mechanisms of Momordicae Semen.
Pharmacological EffectsExtracts or CompoundsMechanismRefs
Anti-inflammatorySaponinsIL-6↓, NO↓, IκBα↓, Src, Syk↓[29,63]
AntioxidantChymotrypsin inhibitorReactive oxygen species↓[64]
Immune adjuvantEthanol extractIgG titers↑[65]
AntibacterialWater extract, saponinsInhibit growth[66]
Kidney cell protectingEthanol extractBlocking the MAPKs signaling cascade[67]
Ulcer healingEthanol extractMucus synthesis↑, cPLA2, 5-LOX↓
Pro-inflammatory cytokines↓
[68]
Induce neurite outgrowth17-kda protein[69]
Reproductive protectingAril extract[70]
Abbrevation: NO: Nitric oxide; IL-6: interleukin- 6; IκBα: inhibitory subunit of NF-kB; Src: Scr kinase; Syk: Sky kinase; IgG: serum immunoglobulin G; MAPK: Mitogen-activated protein kinase; cPLA2: cytosolic phospholipaseA2; 5-LOX: 5-lipoxygenase.

Share and Cite

MDPI and ACS Style

Xu, X.-R.; Luo, C.-H.; Cao, B.; Xu, R.-C.; Wang, F.; Wei, X.-C.; Zhang, T.; Han, L.; Zhang, D.-K. A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen. Molecules 2019, 24, 3949. https://doi.org/10.3390/molecules24213949

AMA Style

Xu X-R, Luo C-H, Cao B, Xu R-C, Wang F, Wei X-C, Zhang T, Han L, Zhang D-K. A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen. Molecules. 2019; 24(21):3949. https://doi.org/10.3390/molecules24213949

Chicago/Turabian Style

Xu, Xiao-Rong, Chuan-Hong Luo, Bo Cao, Run-Chun Xu, Fang Wang, Xi-Chuan Wei, Ting Zhang, Li Han, and Ding-Kun Zhang. 2019. "A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen" Molecules 24, no. 21: 3949. https://doi.org/10.3390/molecules24213949

Article Metrics

Back to TopTop